Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BM-MNC and Hyperbaric Oxygen in T2DM
NCT00767260Phase 2Completed
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Mar 2008
- Primary completion
- Mar 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in type 2 diabetes mellitus (T2DM), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Started Mar 2008; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00767260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767260.